HPK1 INHIBITORS AND METHODS OF USING SAME

Thienopyridinone compounds of Formula (I) and pharmaceutically acceptable salts thereof are described. In these compounds, one of X1; X2, and X3 is S and the other two are each independently CR, wherein R and all other variables are as defined herein. The compounds are shown to inhibit HPK1 kinase a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PAULS, Heinz W, LI, Sze-Wan, LAUFER, Radoslaw, LIU, Yong, PATEL, Narendra Kumar B, SAMPSON, Peter Brent, NG, Grace, LANG, Yunhui
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	PAULS, Heinz W LI, Sze-Wan LAUFER, Radoslaw LIU, Yong PATEL, Narendra Kumar B SAMPSON, Peter Brent NG, Grace LANG, Yunhui
description	Thienopyridinone compounds of Formula (I) and pharmaceutically acceptable salts thereof are described. In these compounds, one of X1; X2, and X3 is S and the other two are each independently CR, wherein R and all other variables are as defined herein. The compounds are shown to inhibit HPK1 kinase activity and to have in vivo antitumor activity. The compounds can be effectively combined with pharmaceutically acceptable carriers and also with other immunomodulatory approaches, such as a checkpoint inhibition or inhibitors of tryptophan oxidation. Formula (I).
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3322711B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3322711B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3322711B13</originalsourceid><addsrcrecordid>eNrjZND0CPA2VPD08_B08gzxDwpWcPRzUfB1DfHwdwlW8HdTCA329HNXCHb0deVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcbGRkbmhoZOhsZEKAEAwzcjlw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HPK1 INHIBITORS AND METHODS OF USING SAME</title><source>esp@cenet</source><creator>PAULS, Heinz W ; LI, Sze-Wan ; LAUFER, Radoslaw ; LIU, Yong ; PATEL, Narendra Kumar B ; SAMPSON, Peter Brent ; NG, Grace ; LANG, Yunhui</creator><creatorcontrib>PAULS, Heinz W ; LI, Sze-Wan ; LAUFER, Radoslaw ; LIU, Yong ; PATEL, Narendra Kumar B ; SAMPSON, Peter Brent ; NG, Grace ; LANG, Yunhui</creatorcontrib><description>Thienopyridinone compounds of Formula (I) and pharmaceutically acceptable salts thereof are described. In these compounds, one of X1; X2, and X3 is S and the other two are each independently CR, wherein R and all other variables are as defined herein. The compounds are shown to inhibit HPK1 kinase activity and to have in vivo antitumor activity. The compounds can be effectively combined with pharmaceutically acceptable carriers and also with other immunomodulatory approaches, such as a checkpoint inhibition or inhibitors of tryptophan oxidation. Formula (I).</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210310&DB=EPODOC&CC=EP&NR=3322711B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210310&DB=EPODOC&CC=EP&NR=3322711B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PAULS, Heinz W</creatorcontrib><creatorcontrib>LI, Sze-Wan</creatorcontrib><creatorcontrib>LAUFER, Radoslaw</creatorcontrib><creatorcontrib>LIU, Yong</creatorcontrib><creatorcontrib>PATEL, Narendra Kumar B</creatorcontrib><creatorcontrib>SAMPSON, Peter Brent</creatorcontrib><creatorcontrib>NG, Grace</creatorcontrib><creatorcontrib>LANG, Yunhui</creatorcontrib><title>HPK1 INHIBITORS AND METHODS OF USING SAME</title><description>Thienopyridinone compounds of Formula (I) and pharmaceutically acceptable salts thereof are described. In these compounds, one of X1; X2, and X3 is S and the other two are each independently CR, wherein R and all other variables are as defined herein. The compounds are shown to inhibit HPK1 kinase activity and to have in vivo antitumor activity. The compounds can be effectively combined with pharmaceutically acceptable carriers and also with other immunomodulatory approaches, such as a checkpoint inhibition or inhibitors of tryptophan oxidation. Formula (I).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND0CPA2VPD08_B08gzxDwpWcPRzUfB1DfHwdwlW8HdTCA329HNXCHb0deVhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcbGRkbmhoZOhsZEKAEAwzcjlw</recordid><startdate>20210310</startdate><enddate>20210310</enddate><creator>PAULS, Heinz W</creator><creator>LI, Sze-Wan</creator><creator>LAUFER, Radoslaw</creator><creator>LIU, Yong</creator><creator>PATEL, Narendra Kumar B</creator><creator>SAMPSON, Peter Brent</creator><creator>NG, Grace</creator><creator>LANG, Yunhui</creator><scope>EVB</scope></search><sort><creationdate>20210310</creationdate><title>HPK1 INHIBITORS AND METHODS OF USING SAME</title><author>PAULS, Heinz W ; LI, Sze-Wan ; LAUFER, Radoslaw ; LIU, Yong ; PATEL, Narendra Kumar B ; SAMPSON, Peter Brent ; NG, Grace ; LANG, Yunhui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3322711B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PAULS, Heinz W</creatorcontrib><creatorcontrib>LI, Sze-Wan</creatorcontrib><creatorcontrib>LAUFER, Radoslaw</creatorcontrib><creatorcontrib>LIU, Yong</creatorcontrib><creatorcontrib>PATEL, Narendra Kumar B</creatorcontrib><creatorcontrib>SAMPSON, Peter Brent</creatorcontrib><creatorcontrib>NG, Grace</creatorcontrib><creatorcontrib>LANG, Yunhui</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PAULS, Heinz W</au><au>LI, Sze-Wan</au><au>LAUFER, Radoslaw</au><au>LIU, Yong</au><au>PATEL, Narendra Kumar B</au><au>SAMPSON, Peter Brent</au><au>NG, Grace</au><au>LANG, Yunhui</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HPK1 INHIBITORS AND METHODS OF USING SAME</title><date>2021-03-10</date><risdate>2021</risdate><abstract>Thienopyridinone compounds of Formula (I) and pharmaceutically acceptable salts thereof are described. In these compounds, one of X1; X2, and X3 is S and the other two are each independently CR, wherein R and all other variables are as defined herein. The compounds are shown to inhibit HPK1 kinase activity and to have in vivo antitumor activity. The compounds can be effectively combined with pharmaceutically acceptable carriers and also with other immunomodulatory approaches, such as a checkpoint inhibition or inhibitors of tryptophan oxidation. Formula (I).</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre ; ger
recordid	cdi_epo_espacenet_EP3322711B1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	HPK1 INHIBITORS AND METHODS OF USING SAME
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A07%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PAULS,%20Heinz%20W&rft.date=2021-03-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3322711B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true